14 related articles for article (PubMed ID: 38444679)
1. Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.
Yang Q; Guo C; Lin X; Luo L; He Z; Lin F; Zhang J; Chen Y; Jiang X; Ke C; Mou Y
Front Pharmacol; 2021; 12():804942. PubMed ID: 35002738
[No Abstract] [Full Text] [Related]
2. Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study.
Yin J; Yin W; Zheng L; Li Y; Luo C; Zhang S; Duan L; Zhou H; Cheng K; Lang J; Xu K
Clin Med Insights Oncol; 2023; 17():11795549231175714. PubMed ID: 37435019
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis.
Shen F; Li J; Liu F; Sun N; Qiu X; Ding W; Sun X
Front Oncol; 2023; 13():1095362. PubMed ID: 36874124
[TBL] [Abstract][Full Text] [Related]
4. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract][Full Text] [Related]
5. Retraction: ZNF655 promotes the progression of glioma through transcriptional regulation of AURKA.
Frontiers Editorial Office
Front Oncol; 2023; 13():1294900. PubMed ID: 38023237
[TBL] [Abstract][Full Text] [Related]
6. Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis.
Frontiers Editorial Office
Front Oncol; 2024; 14():1383410. PubMed ID: 38444679
[TBL] [Abstract][Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]